Since tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, and transforming growth factor (TGF)-beta have all been shown to be specific inhibitors of early human hematopoiesis, we wanted to investigate the interactions of these three cytokines on very primitive human adult bone marrow CD34++CD38- hematopoietic progenitor cells, using a pre-colony-forming cell (pre-CFC) assay, which detects the effects of these cytokines on the initial phases of the differentiation of these primitive progenitors, which are unresponsive to interleukin (IL) 3 alone. Surprisingly, TNF-alpha was a very potent stimulator of the proliferation of CD34++CD38- cells and was the most potent synergistic factor for the IL-3-induced proliferation of these cells of all cytokines tested (IL-1, IL-6, granulocyte colony-stimulating factor, kit ligand). TNF-alpha was the only cytokine that, as a single added factor, induced substantial proliferation in CD34++CD38- cells in the presence of IL-3, except for kit ligand, which induced very limited proliferation. TNF-alpha, moreover, induced a high degree of resistance to the inhibitory effects of TGF-beta in a dose-dependent way. The inhibitory effects of IFN-gamma, however, were not affected by the presence of TNF-alpha. We hypothesize that in situations of the hematopoietic stress, TNF-alpha may abrogate the inhibitory effect of ambient TGF-beta in the bone marrow microenvironment to allow primitive stem cells to proliferate and differentiate in response to an increased demand for mature blood cells.
Skip Nav Destination
Article navigation
1 February 1996
Article|
February 01 1996
Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma.
H W Snoeck,
H W Snoeck
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
Search for other works by this author on:
S Weekx,
S Weekx
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
Search for other works by this author on:
A Moulijn,
A Moulijn
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
Search for other works by this author on:
F Lardon,
F Lardon
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
Search for other works by this author on:
M Lenjou,
M Lenjou
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
Search for other works by this author on:
G Nys,
G Nys
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
Search for other works by this author on:
P C Van Ranst,
P C Van Ranst
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
Search for other works by this author on:
D R Van Bockstaele,
D R Van Bockstaele
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
Search for other works by this author on:
Z N Berneman
Z N Berneman
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
Search for other works by this author on:
H W Snoeck
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
S Weekx
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
A Moulijn
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
F Lardon
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
M Lenjou
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
G Nys
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
P C Van Ranst
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
D R Van Bockstaele
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
Z N Berneman
Laboratory of Experimental Hematology, University of Antwerp, Belgium.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1996) 183 (2): 705–710.
Citation
H W Snoeck, S Weekx, A Moulijn, F Lardon, M Lenjou, G Nys, P C Van Ranst, D R Van Bockstaele, Z N Berneman; Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma.. J Exp Med 1 February 1996; 183 (2): 705–710. doi: https://doi.org/10.1084/jem.183.2.705
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement